LRP1 and neoplasm: Our results uncover a novel regulatory circuit driving melanoma growth (Figure 5F): Induction of p53—as achieved in this study by YO-2 treatment—increases the expression of the critical tumor suppressor miR-107, a miRNA that under non-malignant conditions keeps LRP1 expression, and thereby cell proliferation, at bay.